• Profile
Close

Outcomes following SARS-CoV-2 infection in liver transplant recipients: An international registry study

The Lancet: Gastroenterology & Hepatology Sep 02, 2020

Webb GJ, Marjot T, Cook JA, et al. - Researchers investigated the clinical outcomes in patients with laboratory-confirmed SARS-CoV-2 infection, who were older than 18 years, who had previously received a liver transplant. Assessing data submitted by clinicians to one of two international registries (COVID-Hep and SECURE-Cirrhosis) at the end of the patient's disease course, they collected data for 151 adult liver transplant recipients from 18 countries (median age 60 years, 102 [68%] men, 49 [32%] women) and 627 patients who had not undergone liver transplantation (median age 73 years, 329 [52%] men, 298 [48%] women). Regarding the proportion of patients hospitalized or who required intensive care, there was no difference between the groups, though, in the liver transplant cohort, ICU admission and invasive ventilation were seen more often. Analysis revealed mortality among these cases had independent correlation with higher age and presence of comorbidities, but not with liver transplantation. They emphasize preferentially considering factors other than transplantation relative to physical distancing and medical care for patients with liver transplants during the COVID-19 pandemic.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay